1[1]Murray CJ,Lopez AD.Alternative projections of mortality and disability by cause 1990-2020:Global Burden of Disease Study[J].Lancet,1997,349(9064):1498-1504.
2[2]Anthonisen NR,Manfreda J,Warren CP,et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[J].Ann Intern Med,1987,106(2):196-204.
3[3]Seemungal TA,Harper-Owen R,Bhowmik A,et al.Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease[J].Eur Respir J,2000,16(4):677-683.
4[4]Stockley RA,Bayley D,Hill SL,et al.Assessment of airway neutrophils by sputum colour:correlation with airways inflammation[J].Thorax,2001,56(5):366-372.
5[5]Stockley RA,O'Brien C,Pye A,et al.Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD[J].Chest,2000,117(6):1638-1645.
6[6]Seemungal TA,Harper-Owen R,Bhowmik A,et al.Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease[J].Eur Respir J,2000,16(4):677-683.
7[7]Seemungal TA,Harper-Owen R,Bhowmik A,et al.Respiratory viruses,symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,164(9):1618-1623.
8[8]Rodriguez-Roisin R.Toward a consensus definition for COPD exacerbations[J].Chest,2000,117(5 Suppl 2):S398-S401.
9[9]National Collaborating Centre for Chronic Conditions.Chronic obstructive pulmonary disease.National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care[J].Thorax,2004,59(Suppl 1):1-232.
10[10]Celli BR,MacNee W,Agusti A,et al.Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[J].Eur Respir J,2004,23(1):932-946.
